Literature DB >> 23489620

Synthesis and evaluation of cholecystokinin trimers: a multivalent approach to pancreatic cancer detection and treatment.

Nabila Brabez1, Kevin L Nguyen, Kara Saunders, Ryan Lacy, Liping Xu, Robert J Gillies, Ronald M Lynch, Gerard Chassaing, Solange Lavielle, Victor J Hruby.   

Abstract

In the quest for novel tools for early detection and treatment of cancer, we propose the use of multimers targeting overexpressed receptors at the cancer cell surface. Indeed, multimers are prone to create multivalent interactions, more potent and specific than their corresponding monovalent versions, thus enabling the potential for early detection. There is a lack of tools for early detection of pancreatic cancer, one of the deadliest forms of cancer, but CCK2-R overexpression on pancreatic cancer cells makes CCK based multimers potential markers for these cells. In this Letter, we describe the synthesis and evaluation of CCK trimers targeting overexpressed CCK2-R.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23489620      PMCID: PMC4007200          DOI: 10.1016/j.bmcl.2013.02.022

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

1.  Influencing receptor-ligand binding mechanisms with multivalent ligand architecture.

Authors:  Jason E Gestwicki; Christopher W Cairo; Laura E Strong; Karolyn A Oetjen; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2002-12-18       Impact factor: 15.419

Review 2.  Hitting multiple targets with multimeric ligands.

Authors:  Heather L Handl; Josef Vagner; Haiyong Han; Eugene Mash; Victor J Hruby; Robert J Gillies
Journal:  Expert Opin Ther Targets       Date:  2004-12       Impact factor: 6.902

Review 3.  Cholecystokinin and gastrin receptors.

Authors:  Marlène Dufresne; Catherine Seva; Daniel Fourmy
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

4.  Development of a lanthanide-based assay for detection of receptor-ligand interactions at the delta-opioid receptor.

Authors:  Heather L Handl; Josef Vagner; Henry I Yamamura; Victor J Hruby; Robert J Gillies
Journal:  Anal Biochem       Date:  2005-08-15       Impact factor: 3.365

Review 5.  Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression.

Authors:  Shuyu Li; Shuguang Huang; Sheng-Bin Peng
Journal:  Int J Oncol       Date:  2005-11       Impact factor: 5.650

Review 6.  CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology.

Authors:  F Noble; B P Roques
Journal:  Prog Neurobiol       Date:  1999-07       Impact factor: 11.685

Review 7.  Lanthanide-based luminescent assays for ligand-receptor interactions.

Authors:  Heather L Handl; Robert J Gillies
Journal:  Life Sci       Date:  2005-02-19       Impact factor: 5.037

Review 8.  Cholecystokinin.

Authors:  Rashmi Chandra; Rodger A Liddle
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2007-02       Impact factor: 3.243

Review 9.  Peptide receptors as molecular targets for cancer diagnosis and therapy.

Authors:  Jean Claude Reubi
Journal:  Endocr Rev       Date:  2003-08       Impact factor: 19.871

10.  CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.

Authors:  P J Corringer; J H Weng; B Ducos; C Durieux; P Boudeau; A Bohme; B P Roques
Journal:  J Med Chem       Date:  1993-01-08       Impact factor: 7.446

View more
  4 in total

1.  One-step (18)F labeling of biomolecules using organotrifluoroborates.

Authors:  Zhibo Liu; Kuo-Shyan Lin; François Bénard; Maral Pourghiasian; Dale O Kiesewetter; David M Perrin; Xiaoyuan Chen
Journal:  Nat Protoc       Date:  2015-08-27       Impact factor: 13.491

Review 2.  Principles in the design of ligand-targeted cancer therapeutics and imaging agents.

Authors:  Madduri Srinivasarao; Chris V Galliford; Philip S Low
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

3.  Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor.

Authors:  N G R Dayan Elshan; Thanuja Jayasundera; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2015-02-26       Impact factor: 3.641

4.  Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties.

Authors:  Susanne Kossatz; Rosalba Mansi; Martin Béhé; Peter Czerney; Ingrid Hilger
Journal:  EJNMMI Res       Date:  2013-11-15       Impact factor: 3.138

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.